Article

Pathways and microRNAs bioinformatics analyses identifying possible existing therapeutics for COVID-19 treatment

2020-05-21

Abstract excerpt

Over 180.000 SARS-COV-2 positive cases have been confirmed in Italy as April 20, with the number of deaths exceeding 23 thousand, making Italy the second Country for world COVID-19 deaths. Such enormous occurrence of infected and dead people raises the urgent demand of effective fast available treatments to control and diminish this pandemic. Discovering the cellular/molecular mechanisms of SARS-COV-2 pathogenicit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 48ca5bc8-5d9a-53eb-b516-b50e99974e56
DOI: 10.21203/rs.3.rs-30411/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pathways and microRNAs bioinformatics analyses identifying possible existing therapeutics for COVID-19 treatmentDOI 10.21203/rs.3.rs-30411/v1Read

Pathways and microRNAs bioinformatics analyses identifying possible existing therapeutics for COVID-19 treatmentSemantic proximity Read

MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti‐COVID‐19 TherapeuticsSemantic proximity Read

Potential COVID‐19 therapeutic approaches targeting angiotensin‐converting enzyme 2; An updated reviewSemantic proximity Read

A systems‐level study reveals host‐targeted repurposable drugs against SARS‐CoV‐2 infectionSemantic proximity Read

Identification of potential biomarkers and inhibitors for SARS-CoV-2 infectionSemantic proximity Read

A computational and bioinformatic analysis of ACE2: an elucidation of its dual role in COVID-19 pathology and finding its associated partners as potential therapeutic targetsSemantic proximity Read

COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbiditySemantic proximity Read

A protein interaction map identifies existing drugs targeting SARS-CoV-2Semantic proximity Read

SARS-CoV-2 proteins exploit host’s genetic and epigenetic mediators for the annexation of key host signaling pathways that confers its immune evasion and disease pathophysiologySemantic proximity Read

Network-Based Analysis of Fatal Comorbidities of COVID-19 and Potential TherapeuticsSemantic proximity Read

Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.Semantic proximity Read

Bioinformatic approaches towards identification of potential repurposable drugs for COVID-19Semantic proximity Read